Mice with genetic muscular dystrophy were treated with intraperitoneal injections of the proteinase inhibitor leupeptin, beginning before the onset of weakness. A significant number of the treated animals failed to develop histological evidence of dystrophy, compared with controls. Leupeptin treatment prevented (or delayed) the onset of muscular dystrophy in this experiment.
No takes yet. Share an insight, caveat, or question.
Sher et al. (1981) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: